Omega Therapeutics Analyst Ratings
Omega Therapeutics Price Target Maintained With a $12.00/Share by Wedbush
Omega Therapeutics Analyst Ratings
Omega Therapeutics Analyst Ratings
Omega Therapeutics Analyst Ratings
Buy Rating Reaffirmed for Omega Therapeutics on Strong Clinical and Financial Performance
Analysts' Top Healthcare Picks: Fresenius Medical Care AG & Co. KGaA (GB:0H9X), Omega Therapeutics (OMGA)
Omega Therapeutics Analyst Ratings
Buy Rating Affirmed for Omega Therapeutics Amid Strong Financials and Promising OTX-2002 Clinical Trials
Analysts Conflicted on These Healthcare Names: Annovis Bio (ANVS), Gilead Sciences (GILD) and Omega Therapeutics (OMGA)
Omega Therapeutics Analyst Ratings
Omega Therapeutics Analyst Ratings
Piper Sandler Reiterates Overweight on Omega Therapeutics, Lowers Price Target to $9
Omega Therapeutics (OMGA) Receives a Buy From Piper Sandler
Omega Therapeutics Analyst Ratings
Piper Sandler Remains a Buy on Omega Therapeutics (OMGA)
Buy Rating on Omega Therapeutics: Innovative Obesity Treatment Through Strategic Novo Nordisk Collaboration
Wedbush Reiterates Outperform on Omega Therapeutics, Maintains $12 Price Target
Omega Therapeutics Analyst Ratings
Piper Sandler Sticks to Their Buy Rating for Omega Therapeutics (OMGA)